Contact

All Stories

  1. What Patients With Asthma Share When No One Listens: Multimethod Observational Study of Patient Narratives on Reddit

    Article • Journal of Medical Internet Research, January 2026, JMIR Publications Inc.

    Professor Ignacio Jesús Dávila

  2. Investigating human IgE antibody interactions with pollen-derived sporopollenin biopolymers: Immunoreactivity profiling for the rational design of structurally robust and biocompatible biomaterials

    Article • Biomedical Materials, December 2025, Institute of Physics Publishing

    Professor Ignacio Jesús Dávila

  3. Minocycline‐Induced Delayed Dermographism With Tolerance to Doxycycline

    Article • The Journal of Dermatology, November 2025, Wiley

    Professor Ignacio Jesús Dávila

  4. Evaluation of Real-World Quality of Asthma Care According to the Spanish Consensus Protocol: The AsmaNET Project (ESR-20-20897)

    Article • Journal of Asthma and Allergy, July 2025, Taylor & Francis

    Professor Ignacio Jesús Dávila

  5. Gestión eficiente de agendas de asma grave

    Article • Open Respiratory Archives, July 2025, Elsevier

    Professor Ignacio Jesús Dávila

  6. Stability of Fractional Exhaled Nitric Oxide and Its Relationship With Exacerbation in Patients Aged 6 Years or Older With Uncontrolled, Moderate-to-Severe Asthma

    Article • CHEST Journal, June 2025, Elsevier

    Professor Ignacio Jesús Dávila

  7. What Patients With Asthma Share When No One Listens: Multimethod Observational Study of Patient Narratives on Reddit (Preprint)

    Article • May 2025, JMIR Publications Inc.

    Professor Ignacio Jesús Dávila

  8. Measuring Food-Specific-IgG4s With Milk

    Article • The American Journal of Gastroenterology, May 2025, Wolters Kluwer Health

    Professor Ignacio Jesús Dávila

  9. A RETROSPECTIVE REAL-WORLD STUDY OF PHADIATOP USE AND ITS IMPACT ON REFERRALS TO ALLERGY SPECIALISTS IN A HEALTH AREA

    Article • March 2025, Wiley

    Professor Ignacio Jesús Dávila

  10. TSLP and TSLPR Expression Levels in Peripheral Blood as Potential Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps

    Article • International Journal of Molecular Sciences, January 2025, MDPI AG

    Professor Ignacio Jesús Dávila

  11. Tslp and Tslpr Expression Levels in Peripheral Blood as Potential Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps

    Article • December 2024, MDPI AG

    Professor Ignacio Jesús Dávila

  12. Evaluation Checklist for the Multidisciplinary Approach to Patients with Asthma or Suspected Asthma in United Airway Disease

    Article • Journal of Asthma and Allergy, December 2024, Taylor & Francis

    Professor Ignacio Jesús Dávila

  13. Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough

    Article • Respiratory Investigation, November 2024, Elsevier

    Professor Ignacio Jesús Dávila

  14. Assessment of sIgE to rLep d 2 for detecting Lepidoglyphus destructor sensitization

    Article • Allergy, August 2024, Wiley

    Professor Ignacio Jesús Dávila

  15. The Role of the Gut and Airway Microbiota in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review

    Article • International Journal of Molecular Sciences, July 2024, MDPI AG

    Professor Ignacio Jesús Dávila

  16. Assessment of sIgE to rLep d 2 for Detecting Lepidoglyphus destructor Sensitization

    Article • May 2024, Wiley

    Professor Ignacio Jesús Dávila

  17. Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings

    Article • International Journal of Clinical Pharmacy, April 2024, Springer Science + Business Media

    Professor Ignacio Jesús Dávila

  18. An Exceptional Case of Recall Phenomenon to Hypersensitivity to Amoxicillin

    Article • Dermatitis, October 2023, Mary Ann Liebert Inc

    Professor Ignacio Jesús Dávila

  19. Contact Palpebral Dermatitis and Conjunctivitis Due to Delayed Hypersensitivity to Timolol

    Article • Dermatitis, October 2023, Mary Ann Liebert Inc

    Professor Ignacio Jesús Dávila

  20. Impact of the ERS/ATS 2021 guidelines for lung function interpretation on assessing the response to biologics in asthma

    Article • Journal of Investigational Allergology and Clinical Immunology, September 2023, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  21. Burden of refractory and unexplained chronic cough on patients’ lives: a cohort study

    Article • ERJ Open Research, September 2023, European Respiratory Society (ERS)

    Professor Ignacio Jesús Dávila

  22. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Article • Allergy, August 2023, Wiley

    Professor Ignacio Jesús Dávila

  23. Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R....

    Article • Respiratory Medicine, August 2023, Elsevier

    Professor Ignacio Jesús Dávila

  24. Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis

    Article • Biomedicines, July 2023, MDPI AG

    Professor Ignacio Jesús Dávila

  25. Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force

    Article • Journal of Investigational Allergology and Clinical Immunology, June 2023, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  26. Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature

    Article • International Journal of Immunopathology and Pharmacology, May 2023, SAGE Publications

    Professor Ignacio Jesús Dávila

  27. ALERGODATA: Sentinel registry of health outcomes in allergic patients treated with biological therapies from specialized allergology clinics in Spain

    Article • Journal of Investigational Allergology and Clinical Immunology, May 2023, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  28. Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study

    Article • Lung, May 2023, Springer Science + Business Media

    Professor Ignacio Jesús Dávila

  29. Avances en el manejo del asma difícil de tratar y asma grave

    Article • May 2023, Universidad Internacional de Andalucia

    Professor Ignacio Jesús Dávila

  30. A Prospective Study of Costs Associated With the Evaluation of Allergic Reactions to Radiological Contrast Media

    Article • Journal of Investigational Allergology and Clinical Immunology, April 2023, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  31. Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study

    Article • The Journal of Allergy and Clinical Immunology In Practice, March 2023, Elsevier

    Professor Ignacio Jesús Dávila

  32. Sensitization Phenotypes in Immediate Hypersensitivity to Cephalosporins: A Cluster Analysis Study

    Article • Journal of Investigational Allergology and Clinical Immunology, December 2022, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  33. Severity and duration of allergic conjunctivitis: are they associated with severity and duration of allergic rhinitis and asthma?

    Article • European Annals of Allergy and Clinical Immunology, October 2022, Edra SpA

    Professor Ignacio Jesús Dávila

  34. RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation

    Article • Journal of Physiology and Biochemistry, September 2022, Springer Science + Business Media

    Professor Ignacio Jesús Dávila

  35. Management of United Airway Disease Focused on Patients With Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review

    Article • The Journal of Allergy and Clinical Immunology In Practice, September 2022, Elsevier

    Professor Ignacio Jesús Dávila

  36. Response to monoclonal antibodies in asthma: definitions, potential reasons for failure and therapeutic options for suboptimal response

    Article • Journal of Investigational Allergology and Clinical Immunology, August 2022, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  37. Changes in Sensitization Patterns in the Last 25 Years in 619 Patients with Confirmed Diagnoses of Immediate Hypersensitivity Reactions to Beta-Lactams

    Article • Biomedicines, June 2022, MDPI AG

    Professor Ignacio Jesús Dávila

  38. Cluster Subanalysis of Patients With Severe Asthma Who Responded to Omalizumab

    Article • Journal of Investigational Allergology and Clinical Immunology, June 2022, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  39. Environmental drivers of the seasonal exposure to airborne Alternaria spores in Spain

    Article • The Science of The Total Environment, June 2022, Elsevier

    Professor Ignacio Jesús Dávila

  40. Dupilumab: A Review of Present Indications and Off-Label Uses

    Article • Journal of Investigational Allergology and Clinical Immunology, April 2022, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  41. Polymorphisms in Human IL4, IL10, and TNF Genes Are Associated with an Increased Risk of Developing NSAID-Exacerbated Respiratory Disease

    Article • Genes, March 2022, MDPI AG

    Professor Ignacio Jesús Dávila

  42. Hypersensitivity to Gadolinium-Based Contrast Media

    Article • Frontiers in Allergy, March 2022, Frontiers

    Professor Ignacio Jesús Dávila

  43. Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion

    Article • The Journal of Allergy and Clinical Immunology In Practice, February 2022, Elsevier

    Professor Ignacio Jesús Dávila

  44. Effects of Therapeutic Antibodies on Gene and Protein Signatures in Asthma Patients: A Comparative Systematic Review

    Article • Biomedicines, January 2022, MDPI AG

    Professor Ignacio Jesús Dávila

  45. Patterns of Cross-Reactivity in Patients With Immediate Hypersensitivity Reactions to Gadobutrol

    Article • Journal of Investigational Allergology and Clinical Immunology, December 2021, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  46. Integration of in vitro allergy test results and ratio analysis for the diagnosis and treatment of allergic patients (INTEGRA)

    Article • Clinical and Translational Allergy, September 2021, Wiley

    Professor Ignacio Jesús Dávila

  47. PTGDR2 Expression in Peripheral Blood as a Potential Biomarker in Adult Patients with Asthma

    Article • Journal of Personalized Medicine, August 2021, MDPI AG

    Professor Ignacio Jesús Dávila

  48. Delayed Reaction to Gadobutrol in a Nurse With Myocarditis After SARS-Cov-2 Infection

    Article • Journal of Investigational Allergology and Clinical Immunology, July 2021, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  49. Genetics and Epigenetics of Nasal Polyposis: A Systematic Review

    Article • Journal of Investigational Allergology and Clinical Immunology, June 2021, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  50. Reply to “Delayed hypersensitivity reactions to piperacillin-tazobactam”

    Article • The Journal of Allergy and Clinical Immunology In Practice, June 2021, Elsevier

    Professor Ignacio Jesús Dávila

  51. ARADyAL: The Spanish Multidisciplinary Research Network for Allergic Diseases

    Article • Journal of Investigational Allergology and Clinical Immunology, April 2021, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila, Dr Marta Ferrer

  52. Increased TPSAB1 Copy Number in a Family With Elevated Basal Serum Levels of Tryptase

    Article • Frontiers in Medicine, April 2021, Frontiers

    Professor Ignacio Jesús Dávila

  53. Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement

    Article • Journal of Investigational Allergology and Clinical Immunology, February 2021, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  54. A Comprehensive Prospective Study of the Costs Associated With Evaluation of ß-Lactam Allergy

    Article • Journal of Investigational Allergology and Clinical Immunology, February 2021, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  55. Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma

    Article • Frontiers in Medicine, February 2021, Frontiers

    Professor Ignacio Jesús Dávila

  56. Real‐life study in non‐atopic severe asthma patients achieving disease control by omalizumab treatment

    Article • Allergy, December 2020, Wiley

    Professor Ignacio Jesús Dávila

  57. Pollen-Induced Allergic Asthma and Rhinoconjunctivitis: Differences in Outcome Between Seasonal and Nonseasonal Exposure to Allergens Under Real-Life Conditions (The LANDSCAPE Study)

    Article • Journal of Investigational Allergology and Clinical Immunology, December 2020, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  58. Analysis of the Costs Associated With the Elective Evaluation of Patients Labelled as Allergic to Beta-Lactams or Nonsteroidal Antiinflamatory Agents

    Article • Frontiers in Pharmacology, November 2020, Frontiers

    Professor Ignacio Jesús Dávila

  59. Precision Medicine in House Dust Mite-Driven Allergic Asthma

    Article • Journal of Clinical Medicine, November 2020, MDPI AG

    Professor Ignacio Jesús Dávila

  60. Usefulness of an Artificial Neural Network in the Prediction of β-Lactam Allergy

    Article • The Journal of Allergy and Clinical Immunology In Practice, October 2020, Elsevier

    Professor Ignacio Jesús Dávila

  61. Sensitization phenotypes in immediate reactions to piperacillin-tazobactam

    Article • The Journal of Allergy and Clinical Immunology In Practice, October 2020, Elsevier

    Professor Ignacio Jesús Dávila

  62. Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score.

    Article • September 2020, Authorea, Inc.

    Professor Ignacio Jesús Dávila

  63. A Prospective Study of Costs Associated with the Evaluation of β-Lactam Allergy in Children

    Article • The Journal of Pediatrics, August 2020, Elsevier

    Professor Ignacio Jesús Dávila

  64. Cheilitis Associated With Sensitization to Penicillium notatum in a Clarinetist

    Article • Journal of Investigational Allergology and Clinical Immunology, July 2020, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  65. Urban atmospheric levels of allergenic pollen: comparison of two locations in Salamanca, Central-Western Spain

    Article • Environmental Monitoring and Assessment, June 2020, Springer Science + Business Media

    Professor Ignacio Jesús Dávila

  66. <p>FENOMA Study: Achieving Full Control in Patients with Severe Allergic Asthma</p>

    Article • Journal of Asthma and Allergy, May 2020, Taylor & Francis

    Professor Ignacio Jesús Dávila

  67. COVID-19, asthma, and biological therapies: What we need to know

    Article • World Allergy Organization Journal, May 2020, Elsevier

    Professor Ignacio Jesús Dávila

  68. Promoter Genotyping and mRNA Expression – Based Analysis of the PTGDR Gene in Allergy

    Article • Journal of Investigational Allergology and Clinical Immunology, April 2020, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  69. Genetics and Epigenetics of Atopic Dermatitis: An Updated Systematic Review

    Article • Genes, April 2020, MDPI AG

    Professor Ignacio Jesús Dávila

  70. Atopy Can Be an Interfering Factor in Genetic Association Studies of ß-Lactam Allergy

    Article • Journal of Investigational Allergology and Clinical Immunology, February 2020, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  71. A prospective study of costs associated to the evaluation of non‐steroidal anti‐inflammatory hypersensitivity reactions

    Article • Allergy, January 2020, Wiley

    Professor Ignacio Jesús Dávila

  72. Severe asthma phenotypes in patients controlled with omalizumab: A real-world study

    Article • Respiratory Medicine, November 2019, Elsevier

    Professor Ignacio Jesús Dávila

  73. Relationship between CRTH2 mRNA expression in peripheral blood and IgE and eosinophil levels in adult patients with asthma

    Article • September 2019, European Respiratory Society (ERS)

    Professor Ignacio Jesús Dávila

  74. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

    Article • Journal of Allergy and Clinical Immunology, September 2019, Elsevier

    Professor Ignacio Jesús Dávila

  75. YRNAs overexpression and potential implications in allergy

    Article • World Allergy Organization Journal, August 2019, Elsevier

    Professor Ignacio Jesús Dávila

  76. Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

    Article • Allergy, May 2019, Wiley

    Professor Ignacio Jesús Dávila

  77. Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response

    Article • Journal of Investigational Allergology and Clinical Immunology, April 2019, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila, Dr Marta Ferrer

  78. Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma

    Article • Journal of Investigational Allergology and Clinical Immunology, April 2019, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  79. PTGDR expression is upregulated through retinoic acid receptors (RAR) mechanism in allergy

    Article • PLOS One, April 2019, PLOS

    Professor Ignacio Jesús Dávila

  80. Selection of Biologics in Severe Asthma: A Multifaceted Algorithm

    Article • Journal of Investigational Allergology and Clinical Immunology, April 2019, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  81. Tolerability of iobitridol in patients with non-immediate hypersensitivity reactions to iodinated contrast media

    Article • Allergy, October 2018, Wiley

    Professor Ignacio Jesús Dávila

  82. A case report of fixed drug eruption caused by several drugs because of cross-reactivity and co-sensitization

    Article • Contact Dermatitis, September 2018, Wiley

    Professor Ignacio Jesús Dávila

  83. Adherence to Anaphylaxis Guidelines: Real-World Data From the Emergency Department of a Tertiary Hospital

    Article • Journal of Investigational Allergology and Clinical Immunology, August 2018, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  84. Dupilumab: A New Paradigm for the Treatment of Allergic Diseases

    Article • Journal of Investigational Allergology and Clinical Immunology, June 2018, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  85. Resolution of Type IV Hypersensitivity After Bone Marrow Transplantation

    Article • Journal of Investigational Allergology and Clinical Immunology, June 2018, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  86. Cluster Analysis Identifies 3 Phenotypes within Allergic Asthma

    Article • The Journal of Allergy and Clinical Immunology In Practice, May 2018, Elsevier

    Professor Ignacio Jesús Dávila

  87. Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen

    Article • Pediatric Allergy and Immunology, March 2018, Wiley

    Professor Ignacio Jesús Dávila

  88. Consensus document on dog and cat allergy

    Article • Allergy, February 2018, Wiley

    Professor Ignacio Jesús Dávila

  89. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe

    Article • Rhinology Journal, December 2017, Rhinology

    Dr Marta Ferrer, Professor Ignacio Jesús Dávila

  90. Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study

    Article • September 2017, European Respiratory Society (ERS)

    Professor Ignacio Jesús Dávila

  91. Economic costs of severe asthma in omalizumab-treated patients. FENOMA Study

    Article • September 2017, European Respiratory Society (ERS)

    Professor Ignacio Jesús Dávila

  92. Pharmacogenetics and the treatment of asthma

    Article • Pharmacogenomics, August 2017, Future Medicine

    Professor Ignacio Jesús Dávila

  93. Reproduction of the atopic march in an adult after allogeneic bone marrow transplantation from an atopic sibling

    Article • Annals of Allergy Asthma & Immunology, August 2017, Elsevier

    Professor Ignacio Jesús Dávila

  94. dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies

    Article • International Journal of Molecular Sciences, June 2017, MDPI AG

    Professor Ignacio Jesús Dávila

  95. Acute generalized exanthematous pustulosis (AGEP) induced by azithromycin

    Article • Contact Dermatitis, May 2017, Wiley

    Professor Ignacio Jesús Dávila

  96. Allergic respiratory disease: Different allergens, different symptoms

    Article • Allergy, March 2017, Wiley

    Professor Ignacio Jesús Dávila

  97. Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study

    Article • International Journal of Molecular Sciences, February 2017, MDPI AG

    Professor Ignacio Jesús Dávila

  98. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study

    Article • Allergy, January 2017, Wiley

    Professor Ignacio Jesús Dávila

  99. Performance in real life of the European Network on Drug Allergy algorithm in immediate reactions to beta-lactam antibiotics

    Article • Allergy, September 2016, Wiley

    Professor Ignacio Jesús Dávila

  100. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study

    Article • Pediatric Allergy and Immunology, September 2016, Wiley

    Dr Marta Ferrer, Professor Ignacio Jesús Dávila

  101. Predictive models in drug allergy: An appropriate patient selection is needed

    Article • The Journal of Allergy and Clinical Immunology In Practice, September 2016, Elsevier

    Professor Ignacio Jesús Dávila

  102. Retinoic Acid Modulates PTGDR Promoter Activity

    Article • Journal of Investigational Allergology and Clinical Immunology, July 2016, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  103. Filaggrin gene mutations and new SNPs in asthmatic patients: a cross-sectional study in a Spanish population

    Article • Allergy Asthma & Clinical Immunology, July 2016, Springer Science + Business Media

    Professor Ignacio Jesús Dávila

  104. Relationship between respiratory and food allergy and evaluation of preventive measures

    Article • Allergologia et Immunopathologia, May 2016, Codon Publications

    Professor Ignacio Jesús Dávila

  105. Comparison of Pollen Levels Between 2 Pollen Traps in Salamanca, Spain

    Article • Journal of Investigational Allergology and Clinical Immunology, April 2016, Esmon Publicidad, SA

    Professor Ignacio Jesús Dávila

  106. Effectiveness of omalizumab in severe solar urticaria

    Article • Annals of Allergy Asthma & Immunology, March 2016, Elsevier

    Professor Ignacio Jesús Dávila

  107. Applications of Molecular Genetics to the Study of Asthma

    Article • January 2016, Springer Science + Business Media

    Professor Ignacio Jesús Dávila

  108. Analysis of FOXP3 gene in children with allergy and autoimmune diseases

    Article • Allergologia et Immunopathologia, January 2016, Codon Publications

    Professor Ignacio Jesús Dávila

  109. Genome-wide association studies (GWAS) and their importance in asthma

    Article • Allergologia et Immunopathologia, November 2015, Codon Publications

    Professor Ignacio Jesús Dávila

  110. First case of airborne-induced anaphylaxis triggered by fruit

    Article • Annals of Allergy Asthma & Immunology, August 2015, Elsevier

    Professor Ignacio Jesús Dávila

  111. Implications of cytokine genes in allergic asthma

    Article • Allergologia et Immunopathologia, November 2014, Codon Publications

    Professor Ignacio Jesús Dávila

  112. Genome-wide expression profiling of B lymphocytes reveals IL4R increase in allergic asthma

    Article • Journal of Allergy and Clinical Immunology, October 2014, Elsevier

    Professor Ignacio Jesús Dávila

  113. Olive, grass or both? Molecular diagnosis for the allergen immunotherapy selection in polysensitized pollinic patients

    Article • Allergy, August 2014, Wiley

    Professor Ignacio Jesús Dávila

  114. Characterization of a complex CYP2D6 genotype that caused an AmpliChip CYP450 Test® no-call in the clinical setting

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2014, De Gruyter

    Dr Andrea Gaedigk, Professor Ignacio Jesús Dávila

  115. Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease

    Article • Clinical and Translational Allergy, January 2014, Wiley

    Dr Giorgio Ciprandi, Professor Ignacio Jesús Dávila

  116. Diagnostic and therapeutic approaches in respiratory allergy are different depending on the profile of aeroallergen sensitisation

    Article • Allergologia et Immunopathologia, January 2014, Codon Publications

    Professor Ignacio Jesús Dávila

  117. Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy

    Article • Immunotherapy, December 2013, Future Medicine

    Professor Ignacio Jesús Dávila

  118. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain

    Article • Pediatric Allergy and Immunology, September 2013, Wiley

    Dr Marta Ferrer, Professor Ignacio Jesús Dávila

  119. Bilastine for the treatment of urticaria

    Article • Expert Opinion on Pharmacotherapy, May 2013, Informa Healthcare

    Dr Marta Ferrer, Professor Ignacio Jesús Dávila

  120. Tryptase: Genetic and functional considerations

    Article • Allergologia et Immunopathologia, November 2012, Codon Publications

    Professor Ignacio Jesús Dávila

  121. Reply

    Article • Journal of Allergy and Clinical Immunology, October 2012, Elsevier

    Professor Ignacio Jesús Dávila

  122. Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: the PEDRIAL study

    Article • Allergy, September 2012, Wiley

    Dr Marta Ferrer, Professor Ignacio Jesús Dávila

  123. Aeroallergen Sensitization Influences Quality of Life and Comorbidities in Patients with Nasal Polyposis

    Article • American Journal of Rhinology and Allergy, September 2012, SAGE Publications

    Professor Ignacio Jesús Dávila

  124. Reply

    Article • Journal of Allergy and Clinical Immunology, August 2012, Elsevier

    Professor Ignacio Jesús Dávila

  125. The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification

    Article • Rhinology Journal, March 2012, Rhinology

    Professor Ignacio Jesús Dávila

  126. Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib

    Article • Contact Dermatitis, January 2012, Wiley

    Professor Ignacio Jesús Dávila

  127. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

    Article • Respiratory Research, January 2012, Springer Science + Business Media

    Dr francisco javier fj alvarez gutiérrez, Dr Luis M Entrenas Costa, Professor Ignacio Jesús Dávila

  128. Epigenetic changes in B lymphocytes associated with house dust mite allergic asthma

    Article • Epigenetics, September 2011, Taylor & Francis

    Dr John M. Greally, Professor Ignacio Jesús Dávila

  129. PTGDR gene in asthma: a functional, genetic, and epigenetic study

    Article • Allergy, August 2011, Wiley

    Professor Ignacio Jesús Dávila

  130. Immediate allergic reactions to β-lactams: Diagnostic accuracy of skin tests

    Article • Annals of Allergy Asthma & Immunology, July 2011, Elsevier

    Professor Ignacio Jesús Dávila

  131. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study

    Article • Pediatric Allergy and Immunology, January 2011, Wiley

    Dr Marta Ferrer, Professor Ignacio Jesús Dávila

  132. Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant

    Article • British Journal of Pharmacology, January 2011, Springer Science + Business Media

    Professor Ignacio Jesús Dávila

  133. Airborne pollen calendar of Salamanca, Spain, 2000–2007

    Article • Allergologia et Immunopathologia, November 2010, Elsevier

    Professor Ignacio Jesús Dávila

  134. Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis

    Article • Allergy, October 2010, Wiley

    Professor Ignacio Jesús Dávila

  135. Immunological aspects of nonimmediate reactions to β-lactam antibiotics

    Article • Expert Review of Clinical Immunology, September 2010, Taylor & Francis

    Professor Ignacio Jesús Dávila

  136. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort study

    Article • Rhinology Journal, June 2010, Rhinology

    Dr Marta Ferrer, Professor Ignacio Jesús Dávila

  137. Do genetic factors determine atopy or allergy?

    Article • Allergologia et Immunopathologia, March 2010, Codon Publications

    Professor Ignacio Jesús Dávila

  138. Epigenetic aspects of the allergic diseases

    Article • January 2010, Frontiers in Bioscience

    Professor Ignacio Jesús Dávila

  139. Component‐resolved diagnosis of pollen allergy based on skin testing with profilin, polcalcin and lipid transfer protein pan‐allergens

    Article • Clinical & Experimental Allergy, October 2009, Wiley

    Professor Ignacio Jesús Dávila

  140. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study

    Article • Allergy, September 2009, Wiley

    Professor Ignacio Jesús Dávila

  141. Recurring eczema during pregnancy and after delivery due to sensitization caused by an ultrasound gel

    Article • Ultrasound in Obstetrics and Gynecology, June 2009, Wiley

    Professor Ignacio Jesús Dávila

  142. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts

    Article • British Journal of Dermatology, April 2009, Wiley

    Dr Marta Ferrer, Professor Ignacio Jesús Dávila

  143. A new PTGDR promoter polymorphism in a population of children with asthma

    Article • Pediatric Allergy and Immunology, March 2009, Wiley

    Professor Ignacio Jesús Dávila

  144. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients

    Article • Allergy, December 2008, Wiley

    Professor Ignacio Jesús Dávila

  145. Hypersensitivity reactions to cephalosporins

    Article • Expert Opinion on Drug Safety, May 2008, Informa Healthcare

    Professor Ignacio Jesús Dávila

  146. Molecular Analysis of Activation-Induced Cytidine Deaminase Gene in Immunoglobulin-E Deficient Patients

    Article • Clinical and Developmental Immunology, January 2008, Hindawi Publishing Corporation

    Professor Ignacio Jesús Dávila

  147. Therapeutic Applications of Antisense Oligonucleotides in Asthma and Allergy

    Article • Recent Patents on Inflammation & Allergy Drug Discovery, November 2007, Bentham Science Publishers

    Professor Ignacio Jesús Dávila

  148. Development and Validation of a New Spanish Instrument to Measure Health-Related Quality of Life in Patients with Allergic Rhinitis: The ESPRINT Questionnaire

    Article • Value in Health, November 2007, Elsevier

    Professor Ignacio Jesús Dávila

  149. Usefulness of intradermal test and patch test in the diagnosis of nonimmediate reactions to metamizol

    Article • Allergy, October 2007, Wiley

    Professor Ignacio Jesús Dávila

  150. Proteomic approaches for identifying new allergens and diagnosing allergic diseases

    Article • Clinica Chimica Acta, October 2007, Elsevier

    Professor Ignacio Jesús Dávila

  151. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items

    Article • Journal of Allergy and Clinical Immunology, August 2007, Elsevier

    Professor Ignacio Jesús Dávila

  152. Prevention of allergic diseases

    Article • Allergologia et Immunopathologia, July 2007, Elsevier

    Professor Ignacio Jesús Dávila

  153. Promoter genetic variants of prostanoid DP receptor (PTGDR) gene in patients with asthma

    Article • Allergy, March 2006, Wiley

    Professor Ignacio Jesús Dávila

  154. Interleukin-4 (IL4) and Interleukin-4 receptor (IL4RA) polymorphisms in asthma: a case control study

    Article • Clinical and Molecular Allergy, November 2005, Springer Science + Business Media

    Professor Ignacio Jesús Dávila

  155. El polimorfismo Q576R del gen IL4RA se asocia con valores elevados de IgE total en pacientes con antecedentes familiares de atopia

    Article • Medicina Clínica, February 2005, Elsevier

    Professor Ignacio Jesús Dávila

  156. Analysis of the leukotriene C4 synthase A−444C promoter polymorphism in a Spanish population

    Article • Journal of Allergy and Clinical Immunology, January 2005, Elsevier

    Professor Ignacio Jesús Dávila

  157. Tick-bite-induced anaphylaxis in Spain

    Article • Annals of Tropical Medicine and Parasitology, January 2001, Taylor & Francis

    Professor Ignacio Jesús Dávila

  158. Infección vírica y asma: mecanismos inmunológicos

    Article • Allergologia et Immunopathologia, January 2001, Codon Publications

    Professor Ignacio Jesús Dávila

  159. Interacción de isoniazida con alimentos

    Article • Archivos de Bronconeumología (English Edition), April 1998, Elsevier

    Professor Ignacio Jesús Dávila

  160. Anaphylactic reaction to ranitidine

    Article • Allergy, July 1993, Wiley

    Professor Ignacio Jesús Dávila

  161. Cross‐reactivity between quinolones

    Article • Allergy, July 1993, Wiley

    Professor Ignacio Jesús Dávila

  162. Occupational protein contact dermatitis from herring

    Article • Allergy, July 1993, Wiley

    Professor Ignacio Jesús Dávila

  163. Fixed eruption caused by ciprofloxacin with cross‐sensitivity to norfloxacin

    Article • Allergy, May 1993, Wiley

    Professor Ignacio Jesús Dávila

  164. Hypersensitivity to trimethoprim

    Article • Allergy, August 1992, Wiley

    Professor Ignacio Jesús Dávila

  165. Urticaria from caffeine

    Article • Journal of Allergy and Clinical Immunology, October 1991, Elsevier

    Professor Ignacio Jesús Dávila